AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

December 31, 2008

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

AZD6244

oral vial

DRUG

Pemetrexed

oral

Trial Locations (8)

Unknown

Research Site, Los Angeles

Research Site, Ann Arbor

Research Site, New York

Research Site, Nashville

Research Site, Plovdiv

Research Site, Sofia

Research Site, Varna

Research Site, Cluj-Napoca

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY